Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2004 May;15(3):161-7.
doi: 10.1177/095632020401500306.

Attempt to Reduce Cytotoxicity by Synthesizing the L-enantiomer of 4'-C-ethynyl-2'-deoxypurine Nucleosides as Antiviral Agents Against HIV and HBV

Affiliations

Attempt to Reduce Cytotoxicity by Synthesizing the L-enantiomer of 4'-C-ethynyl-2'-deoxypurine Nucleosides as Antiviral Agents Against HIV and HBV

Kenji Kitano et al. Antivir Chem Chemother. .

Abstract

We investigated the potential of 4'-C-substituted nucleosides for the treatment of HIV-1 and HBV. Of the nucleosides we prepared, several 4'-C-ethynyl-2'-deoxypurine nucleosides showed the most potent anti-HIV activity. However, two candidates, 4'-C-ethynyl-2'-deoxyguanosine and 9-(2-deoxy-4-C-ethynyl-beta-D-ribo-pentofuranosyl)-2,6-diaminopurine, were very toxic during in vivo study. On the other hand, lamivudine (3TC) is known to show remarkable activity against HIV and HBV with lower cytotoxicity. Therefore, we attempted to synthesize the L-enantiomer of 4'-C-ethynyl-2'-deoxypurine nucleosides in 20-21 steps. These methods consisted of preparing 4-C-ethynyl-L-sugar, starting from D-arabinose and then condensing the L-sugar derivative with 2,6-diaminopurine. 4'-C-Ethynyl-2'-deoxyguanosine was also prepared by enzymatic deamination from the 2,6-diaminopurine derivative. The compounds' antiviral activity against HIV and HBV was then evaluated. Unfortunately, they demonstrated no activity and no cytotoxicity.

Similar articles

See all similar articles

Cited by 1 article

Substances

LinkOut - more resources

Feedback